Cristofanilli M - Search Results

1

Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy.

Buchholz TA, Davis DW, McConkey DJ, Symmans WF, Valero V, Jhingran A, Tucker SL, Pusztai L, Cristofanilli M, Esteva FJ, Hortobagyi GN, Sahin AA. Buchholz TA, et al. Among authors: cristofanilli m. Cancer J. 2003 Jan-Feb;9(1):33-41. doi: 10.1097/00130404-200301000-00007. Cancer J. 2003. PMID: 12602766

2

Phase II study of adozelesin in untreated metastatic breast cancer.

Cristofanilli M, Bryan WJ, Miller LL, Chang AY, Gradishar WJ, Kufe DW, Hortobagyi GN. Cristofanilli M, et al. Anticancer Drugs. 1998 Oct;9(9):779-82. doi: 10.1097/00001813-199810000-00006. Anticancer Drugs. 1998. PMID: 9840723 Clinical Trial.

3

Current methods to prevent the development of breast cancer.

Cristofanilli M, Hortobagyi GN. Cristofanilli M, et al. In Vivo. 1998 Nov-Dec;12(6):659-65. In Vivo. 1998. PMID: 9891229 Review.

4

Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience.

Cristofanilli M, Holmes FA, Esparza L, Valero V, Buzdar AU, Neidhart JA, Hortobagyi GN. Cristofanilli M, et al. Breast Cancer Res Treat. 1999 Apr;54(3):225-33. doi: 10.1023/a:1006104610727. Breast Cancer Res Treat. 1999. PMID: 10445421 Clinical Trial.

5

Chemo-signal therapy, an emerging new approach to modify drug resistance in breast cancer.

Pusztai L, Esteva FJ, Cristofanilli M, Hung MC, Hortobagyi GN. Pusztai L, et al. Among authors: cristofanilli m. Cancer Treat Rev. 1999 Oct;25(5):271-7. doi: 10.1053/ctrv.1999.0132. Cancer Treat Rev. 1999. PMID: 10544071 Review.

6

Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy.

Buchholz TA, Tucker SL, Erwin J, Mathur D, Strom EA, McNeese MD, Hortobagyi GN, Cristofanilli M, Esteva FJ, Newman L, Singletary SE, Buzdar AU, Hunt KK. Buchholz TA, et al. Among authors: cristofanilli m. J Clin Oncol. 2001 Apr 15;19(8):2240-6. doi: 10.1200/JCO.2001.19.8.2240. J Clin Oncol. 2001. PMID: 11304777

7

Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification.

Seidman AD, Fornier MN, Esteva FJ, Tan L, Kaptain S, Bach A, Panageas KS, Arroyo C, Valero V, Currie V, Gilewski T, Theodoulou M, Moynahan ME, Moasser M, Sklarin N, Dickler M, D'Andrea G, Cristofanilli M, Rivera E, Hortobagyi GN, Norton L, Hudis CA. Seidman AD, et al. Among authors: cristofanilli m. J Clin Oncol. 2001 May 15;19(10):2587-95. doi: 10.1200/JCO.2001.19.10.2587. J Clin Oncol. 2001. PMID: 11352950 Clinical Trial.

8

Paclitaxel in the multimodality treatment for inflammatory breast carcinoma.

Cristofanilli M, Buzdar AU, Sneige N, Smith T, Wasaff B, Ibrahim N, Booser D, Rivera E, Murray JL, Valero V, Ueno N, Singletary ES, Hunt K, Strom E, McNeese M, Stelling C, Hortobagyi GN. Cristofanilli M, et al. Cancer. 2001 Oct 1;92(7):1775-82. doi: 10.1002/1097-0142(20011001)92:7<1775::aid-cncr1693>3.0.co;2-e. Cancer. 2001. PMID: 11745249 Clinical Trial.

9

Automated electrorotation to reveal dielectric variations related to HER-2/neu overexpression in MCF-7 sublines.

Cristofanilli M, De Gasperis G, Zhang L, Hung MC, Gascoyne PR, Hortobagyi GN. Cristofanilli M, et al. Clin Cancer Res. 2002 Feb;8(2):615-9. Clin Cancer Res. 2002. PMID: 11839684

10

New horizons in treating metastatic disease.

Cristofanilli M, Hortobagyi GN. Cristofanilli M, et al. Clin Breast Cancer. 2001 Jan;1(4):276-87. doi: 10.3816/CBC.2001.n.002. Clin Breast Cancer. 2001. PMID: 11899350 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

454 results

Search Page